Precision medicine doubles progression-free survival in young cancer patients

  • Post author:
  • Post category:uncategorized

Cancer is the leading cause of disease-related death in children in most developed countries, and at least a quarter of these patients are diagnosed with aggressive high-risk or relapsed cancers, with an expected five-year survival rate of less than 30%.